Pfizer, Biontech to supply additional 100M doses of COMIRNATY to EU

 

• Pfizer (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) will supply an additional 100M doses of their COVID-19 vaccine COMIRNATY, to the 27 European Union (EU) member states in 2021, bringing the total number of doses to be delivered to the EU to 300M.
• All 300 million doses are expected to be delivered in 2020 and 2021.
• “In partnership with the European Commission, member states and healthcare providers, we will be able to reach a total of 150 million Europeans across the continent,” said Albert Bourla, Pfizer CEO.
• The distribution of COMIRNATY by the EU member states will continue to be determined according to the populations identified in EU and national guidance.
• Pfizer and BioNTech announced on November 11, 2020, that they reached an agreement with the European Commission to supply 200 million doses, with an option for the European Commission to request an additional 100 million doses.
• The companies previously stated their potential to supply up to 1.3 billion doses worldwide by the end of 2021.
• The European Medical Authority reportedly said today that the AstraZeneca/Oxford vaccine might not be approved in January.
• https://seekingalpha.com/news/3647763-pfizer-and-biontech-to-supply-additional-100m-doses-of-comirnaty-to-eu